Skip to main content
. 2018 Oct 10;19(10):3096. doi: 10.3390/ijms19103096

Figure 3.

Figure 3

CCND2 promoter hypermethylation and mRNA expression level and its correlation with survival in lung, breast, and liver cancer patients Data for CCND2 DNA hypermethylation and the mRNA expression level assayed by the Illumina Methylation 450K array-based assay and RNA sequencing and survival data were collected from TCGA. (A,B) Kaplan-Meier survival curves were used to compare the survival between cancer patients with low and high CCND2 mRNA expression levels in breast cancer and lung cancer patients. (C,D) Kaplan–Meier survival curves were used to compare the survival between cancer patients with low and high CCND2 methylation levels in breast cancer and lung cancer patients.